These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 27998232)

  • 1. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
    Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM
    J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer.
    Farias AJ; Du XL
    J Clin Oncol; 2017 Jan; 35(1):86-95. PubMed ID: 28034069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data.
    Farias AJ; Wu WH; Du XL
    BMC Cancer; 2018 Dec; 18(1):1214. PubMed ID: 30514270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
    Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
    Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
    Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison.
    Bakk L
    J Health Care Poor Underserved; 2015 Nov; 26(4):1132-48. PubMed ID: 26548668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
    Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
    Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
    Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
    JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the difference in racial and ethnic disparities in access to and use of care between Traditional Medicare and Medicare Advantage.
    Gangopadhyaya A; Zuckerman S; Rao N
    Health Serv Res; 2023 Aug; 58(4):914-923. PubMed ID: 36894493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Did Medicare Part D reduce disparities?
    Zissimopoulos J; Joyce GF; Scarpati LM; Goldman DP
    Am J Manag Care; 2015 Feb; 21(2):119-28. PubMed ID: 25880361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
    Hershman DL; Tsui J; Wright JD; Coromilas EJ; Tsai WY; Neugut AI
    J Clin Oncol; 2015 Mar; 33(9):1053-9. PubMed ID: 25691670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic disparities in Medicare Part D experiences.
    Haviland AM; Elliott MN; Weech-Maldonado R; Hambarsoomian K; Orr N; Hays RD
    Med Care; 2012 Nov; 50 Suppl(Suppl):S40-7. PubMed ID: 23064276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?
    Mahmoudi E; Jensen GA
    Health Serv Res; 2014 Apr; 49(2):502-25. PubMed ID: 24102408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
    Jung J; Du P; Feldman R; Kong L; Riley T
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Medicare Part D on Racial Disparities in Adherence to Cardiovascular Medications Among the Elderly.
    Hussein M; Waters TM; Chang CF; Bailey JE; Brown LM; Solomon DK
    Med Care Res Rev; 2016 Aug; 73(4):410-36. PubMed ID: 26577228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer.
    Farias AJ; Wu WH; Du XL
    Med Oncol; 2018 Jun; 35(7):113. PubMed ID: 29926275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.
    Beer L; Mattson CL; Bradley H; Skarbinski J;
    Medicine (Baltimore); 2016 Mar; 95(13):e3171. PubMed ID: 27043679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
    Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
    Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.
    McFall AM; Dowdy DW; Zelaya CE; Murphy K; Wilson TE; Young MA; Gandhi M; Cohen MH; Golub ET; Althoff KN;
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):289-98. PubMed ID: 23797695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.